RIGL — RIGEL PHARMACEUTICALS INC

Ownership history in Range Financial Group LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Range Financial Group LLC reported a position in RIGEL PHARMACEUTICALS INC (RIGL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.68% (2025 Q4)
Avg. % of fund
0.57%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 45,938 +561 +1.2% 0.68% $2.0M $42.83
2025 Q3 INITIATED 45,377 — — 0.46% $1.3M $28.33
% of Fund (quarterly)    RIGL price (monthly, adj. close)

Other funds also holding RIGL

As of 2025 Q4 — sorted by position size

CM Management, LLC 3Y 8.12% GLOBEFLEX CAPITAL L P 3Y 7Y 1.43% Empire Financial Management Company, LLC 0.71% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.54% Soleus Capital Management, L.P. 3Y 0.47% ARMISTICE CAPITAL, LLC 3Y 7Y 0.43% Verdad Advisers, LP 3Y 0.43% Opaleye Management Inc. 3Y 7Y 0.4% Hillsdale Investment Management Inc. 3Y 7Y 0.33% Wakefield Asset Management LLLP 3Y 7Y 0.3%
← Back to Range Financial Group LLC Holdings